Calypte Biomedical Corp. announces initial public offering of common stock.BERKELEY, Calif.--(BUSINESS WIRE)--July 26, 1996--Calypte Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Corp. Friday announced its initial public offering on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on Small Cap Index under the trading symbol CALY. The company listed 2.3 million shares at an initial price of $6.00 per share. Pacific Growth Equities was the managing underwriter of the offering. Calypte Biomedical Corp. is a Berkeley-based health care company dedicated to the development and commercialization of urine-based diagnostic products and services for HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. , sexually transmitted diseases Sexually transmitted diseases Infections that are acquired and transmitted by sexual contact. Although virtually any infection may be transmitted during intimate contact, the term sexually transmitted disease is restricted to conditions that are largely and other chronic illnesses. CONTACT: Calypte Biomedical Corp. John DiPietro or Jack Davis, 510/814-8506 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion